Muzaffar Qazilbash, Director of Myeloma Transplantation and Cellular Therapy at MD Anderson Cancer Center, shared a post on X about a paper he co-authored with colleagues, published in the British Journal of Haematology:
“Inconsistent definitions of transplant ineligibility in multiple myeloma. Among 55 transplant-ineligible trials, only 47% explicitly defined ineligibility criteria.”
Karun Neupane, Hematology/Oncology Fellow at Moffitt Cancer Center, shared this post, adding:
“Grateful for the mentorship and collaboration in this analytical paper, Manni Mohyuddin.
Thank you for your support and for highlighting the summary, Dr. Qazilbash!
Title: Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review
Authors: Karun Neupane, Mitch Singstock, Darshi Shah, Riyasha Dahal, Hira Mian, Febe Smith, Rajshekhar Chakraborty, Samer Al Hadidi, Maria Mainou, Ariel Grajales-Cruz, Syeda Mahrukh Hussnain Naqvi, Kenneth H. Shain, Aaron Goodman, Luciano J. Costa, Muzaffar Qazilbash, Ghulam Rehman Mohyuddin
You can read the Full Article in the British Journal of Haematology.
More posts featuring Muzaffar Qazilbash.